Literature DB >> 3247314

Protein binding of cocaine in human serum.

D J Edwards1, S K Bowles.   

Abstract

The protein binding characteristics of cocaine have not been extensively studied. Since cocaine is related to other local anesthetic compounds which are highly protein bound, we examined the binding of cocaine in human serum using an ultrafiltration method. The free fraction averaged 0.083 +/- 0.018 in the serum of 12 healthy volunteers. Binding was studied at concentrations ranging from 0.1 to 500 micrograms/ml and was concentration dependent, with increases being most pronounced at concentrations above 5 micrograms/ml. Two classes of binding sites were identified with affinity and capacity constants consistent with binding to alpha-1-acid glycoprotein (AAG) and albumin. The addition of AAG to serum resulted in a decrease in the free fraction from 0.079 to 0.041, while tris(butoxyethyl)phosphate increased the free fraction to 0.233. The binding ratio was found to be highly correlated with the AAG concentration (r = 0.89). In addition, the predicted free fraction in the absence of AAG (0.67) was in good agreement with the observed value of 0.647 in a solution of human serum albumin (4.5 g/dl). Of the metabolites of cocaine, only norcocaine displaced the parent drug from serum binding sites. These results indicate that cocaine is highly bound to serum proteins, primarily albumin and AAG. The significance of concentration-dependent binding to cocaine toxicity remains to be established.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3247314     DOI: 10.1023/a:1015992502509

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Kinetics of drug effect by distributed lags analysis: an application to cocaine.

Authors:  R Zahler; P Wachtel; P Jatlow; R Byck
Journal:  Clin Pharmacol Ther       Date:  1982-06       Impact factor: 6.875

2.  Gas chromatography-chemical ionization mass spectrometry of cocaine and its metabolites in biological fluids.

Authors:  D M Chinn; D J Crouch; M A Peat; B S Finkle; T A Jennison
Journal:  J Anal Toxicol       Date:  1980 Jan-Feb       Impact factor: 3.367

3.  Death caused by recreational cocaine use. An update.

Authors:  R E Mittleman; C V Wetli
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

4.  Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate.

Authors:  O Borgå; K M Piafsky; O G Nilsen
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

5.  Cocaine plasma concentration: relation to physiological and subjective effects in humans.

Authors:  J I Javaid; M W Fischman; C R Schuster; H Dekirmenjian; J M Davis
Journal:  Science       Date:  1978-10-13       Impact factor: 47.728

6.  Alpha 1-acid glycoprotein and albumin in human serum bupivacaine binding.

Authors:  D Denson; D Coyle; G Thompson; J Myers
Journal:  Clin Pharmacol Ther       Date:  1984-03       Impact factor: 6.875

7.  Prediction of stability in pharmaceutical preparations XX: stability evaluation and bioanalysis of cocaine and benzoylecgonine by high-performance liquid chromatography.

Authors:  E R Garrett; K Seyda
Journal:  J Pharm Sci       Date:  1983-03       Impact factor: 3.534

8.  Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.

Authors:  J J Lima; H Boudoulas; M Blanford
Journal:  J Pharmacol Exp Ther       Date:  1981-12       Impact factor: 4.030

9.  Kinetics of cocaine distribution, elimination, and chronotropic effects.

Authors:  M J Chow; J J Ambre; T I Ruo; A J Atkinson; D J Bowsher; M W Fischman
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

10.  Factors affecting quinidine protein binding in humans.

Authors:  D J Edwards; J E Axelson; R L Slaughter; A T Elvin; D Lalka
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

View more
  9 in total

1.  Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts.

Authors:  R T Malison; S E Best; E A Wallace; E McCance; M Laruelle; S S Zoghbi; R M Baldwin; J S Seibyl; P B Hoffer; L H Price
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  Cocaine induces alterations in mitochondrial membrane potential and dual cell cycle arrest in rat c6 astroglioma cells.

Authors:  Ramesh B Badisa; Selina F Darling-Reed; Carl B Goodman
Journal:  Neurochem Res       Date:  2009-09-16       Impact factor: 3.996

3.  Mechanisms of acute cocaine toxicity.

Authors:  Kennon Heard; Robert Palmer; Nancy R Zahniser
Journal:  Open Pharmacol J       Date:  2008

Review 4.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

5.  Proteomic analyses of the effects of drugs of abuse on monocyte-derived mature dendritic cells.

Authors:  Jessica L Reynolds; Supriya D Mahajan; Ravikunar Aalinkeel; B Nair; Donald E Sykes; Stanley A Schwartz
Journal:  Immunol Invest       Date:  2009       Impact factor: 3.657

6.  Modulation of the proteome of peripheral blood mononuclear cells from HIV-1-infected patients by drugs of abuse.

Authors:  Jessica L Reynolds; Supriya D Mahajan; Ravikunar Aalinkeel; Bindukumar Nair; Donald E Sykes; Anardi Agosto-Mujica; Chiu Bin Hsiao; Stanley A Schwartz
Journal:  J Clin Immunol       Date:  2009-06-20       Impact factor: 8.317

7.  Cocaine-induced locomotor stimulation involves autophagic degradation of the dopamine transporter.

Authors:  Maged M Harraz; Prasun Guha; Evan R Semenza; Adarsha P Malla; In Guk Kang; Young Jun Song; Luke Reilly; Isaac Treisman; Pedro Cortés; Mark A Coggiano; Vijayabhaskar Veeravalli; Rana Rais; Gianluigi Tanda; Solomon H Snyder
Journal:  Mol Psychiatry       Date:  2021-01-07       Impact factor: 15.992

Review 8.  Cocaine: An Updated Overview on Chemistry, Detection, Biokinetics, and Pharmacotoxicological Aspects including Abuse Pattern.

Authors:  Rita Roque Bravo; Ana Carolina Faria; Andreia Machado Brito-da-Costa; Helena Carmo; Přemysl Mladěnka; Diana Dias da Silva; Fernando Remião
Journal:  Toxins (Basel)       Date:  2022-04-13       Impact factor: 5.075

9.  Probing cocaine-antibody interactions in buffer and human serum.

Authors:  Muthu Ramakrishnan; Fernando Alves De Melo; Berma M Kinsey; John E Ladbury; Thomas R Kosten; Frank M Orson
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.